Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial - Concepedia

Concepedia

Publication | Closed Access

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial

94

Citations

21

References

2002

Year

Cherri M. Miner, Eileen Brown, Susan McCray, Jill Gonzales, Madelaine M. Wohlreich

Clinical Therapeutics

MedicinePsychopharmacologyEnteric-coated Fluoxetine 90Social SciencesPharmacotherapyMood DisordersWeekly Luteal-phasePharmacologyPsychopathologyPlacebo-controlled Clinical TrialSide Effect

References

	Year	Citations

Page 1